Innoviva (INVA) Liabilities and Shareholders Equity (2010 - 2026)

Innoviva (INVA) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 46.41% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $6.2 billion (up 24.39% YoY), and the FY2025 full-year result was $1.6 billion, up 25.68% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $1.8 billion, up from $1.6 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $1.8 billion in Q1 2026 and bottomed at $1.1 billion in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $1.2 billion (2023), against an average of $1.3 billion.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity soared 49.65%; it then declined 10.51% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.2 billion in 2022, then rose by 0.98% to $1.2 billion in 2023, then rose by 4.63% to $1.3 billion in 2024, then grew by 25.68% to $1.6 billion in 2025, then gained by 12.32% to $1.8 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.8 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.

Peer Comparison